These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16098018)

  • 1. Copper-replacement treatment for symptomatic Menkes disease: ethical considerations.
    Sheela SR; Latha M; Liu P; Lem K; Kaler SG
    Clin Genet; 2005 Sep; 68(3):278-83. PubMed ID: 16098018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.
    Kim JH; Lee BH; Kim YM; Choi JH; Kim GH; Cheon CK; Yoo HW
    Metab Brain Dis; 2015 Feb; 30(1):75-81. PubMed ID: 24919650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T1048I mutation in ATP7A gene causes an unusual Menkes disease presentation.
    León-García G; Santana A; Villegas-Sepúlveda N; Pérez-González C; Henrríquez-Esquíroz JM; de León-García C; Wong C; Baeza I
    BMC Pediatr; 2012 Sep; 12():150. PubMed ID: 22992316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
    Haddad MR; Macri CJ; Holmes CS; Goldstein DS; Jacobson BE; Centeno JA; Popek EJ; Gahl WA; Kaler SG
    Mol Genet Metab; 2012 Sep; 107(1-2):222-8. PubMed ID: 22695177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small In-frame deletion.
    Kaler SG; Das S; Levinson B; Goldstein DS; Holmes CS; Patronas NJ; Packman S; Gahl WA
    Biochem Mol Med; 1996 Feb; 57(1):37-46. PubMed ID: 8812725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menkes disease mutations and response to early copper histidine treatment.
    Kaler SG
    Nat Genet; 1996 May; 13(1):21-2. PubMed ID: 8673098
    [No Abstract]   [Full Text] [Related]  

  • 7. A copper treatable Menkes disease mutation associated with defective trafficking of a functional Menkes copper ATPase.
    Kim BE; Smith K; Petris MJ
    J Med Genet; 2003 Apr; 40(4):290-5. PubMed ID: 12676902
    [No Abstract]   [Full Text] [Related]  

  • 8. Defective copper-induced trafficking and localization of the Menkes protein in patients with mild and copper-treated classical Menkes disease.
    Ambrosini L; Mercer JF
    Hum Mol Genet; 1999 Aug; 8(8):1547-55. PubMed ID: 10401004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical manifestations of Menkes disease vary according to patient's genotype and the initiation time of treatment with copper-histidine injections].
    Yagi M; Kusunoki N; Lee T; Awano H; Kodama H; Takeshima Y; Iijima K
    No To Hattatsu; 2014 May; 46(3):227-8. PubMed ID: 24902345
    [No Abstract]   [Full Text] [Related]  

  • 10. A Truncating De Novo Point Mutation in a Young Infant with Severe Menkes Disease.
    Lin YJ; Ho CS; Hsu CH; Lin JL; Chuang CK; Tsai JD; Chiu NC; Lin HY; Lin SP
    Pediatr Neonatol; 2017 Feb; 58(1):89-92. PubMed ID: 25771438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopment and brain growth in classic Menkes disease is influenced by age and symptomatology at initiation of copper treatment.
    Kaler SG
    J Trace Elem Med Biol; 2014 Oct; 28(4):427-30. PubMed ID: 25281031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene symbol: ATP7A. Disease: Menkes disease.
    Tumer Z; Horn N; Tonnesen T; Christodoulou J; Clarke JT; Sarkar B
    Hum Genet; 2004 May; 114(6):606. PubMed ID: 15176369
    [No Abstract]   [Full Text] [Related]  

  • 13. Variable clinical expression of an identical mutation in the ATP7A gene for Menkes disease/occipital horn syndrome in three affected males in a single family.
    Borm B; Møller LB; Hausser I; Emeis M; Baerlocher K; Horn N; Rossi R
    J Pediatr; 2004 Jul; 145(1):119-21. PubMed ID: 15238919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of 383 unrelated patients affected with Menkes disease and finding of 57 gross deletions in ATP7A.
    Tümer Z; Birk Møller L; Horn N
    Hum Mutat; 2003 Dec; 22(6):457-64. PubMed ID: 14635105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal diagnosis and treatment of Menkes disease.
    Kaler SG; Holmes CS; Goldstein DS; Tang J; Godwin SC; Donsante A; Liew CJ; Sato S; Patronas N
    N Engl J Med; 2008 Feb; 358(6):605-14. PubMed ID: 18256395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular correlates of epilepsy in early diagnosed and treated Menkes disease.
    Kaler SG; Liew CJ; Donsante A; Hicks JD; Sato S; Greenfield JC
    J Inherit Metab Dis; 2010 Oct; 33(5):583-9. PubMed ID: 20652413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel mutation in the ATP7A gene in a Korean patient with Menkes disease.
    Kim YH; Lee R; Yoo HW; Yum MS; Bae SH; Chung SC; Park YM; Son JS
    J Korean Med Sci; 2011 Jul; 26(7):951-3. PubMed ID: 21738351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper-histidine therapy in an infant with novel splice-site variant in the
    Panichsillaphakit E; Kwanbunbumpen T; Chomtho S; Visuthranukul C
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35393273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From gene to disease; Menkes disease: copper deficiency due to an ATP7A-gene defect].
    Aldenhoven M; Klomp LW; van Hasselt PM; de Koning TJ; Visser G
    Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2266-70. PubMed ID: 17987894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menkes gene study in the Chinese population.
    Mak BS; Chi CS; Tsai CR
    J Child Neurol; 2002 Apr; 17(4):250-2. PubMed ID: 12088078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.